Wacker Chemie AG buy DerAlmanach100000
Start price
04.12.25
/
100%
€66.45
Target price
18.12.25
-
Performance (%)
0.00%
Price
04.12.25
€66.45
Summary
This prediction is currently active. DerAlmanach100000's BUY prediction for Wacker Chemie AG is currently unchanged. This prediction currently runs until 18.12.25. The prediction end date can be changed by DerAlmanach100000 at any time. DerAlmanach100000 has 100% into this predictionWacker Chemie is a Munich-based chemical company that specializes in manufacturing products for various industries such as construction, automotive, electronics, and pharmaceuticals. The company produces materials that are essential to manufacturing products such as adhesives, sealants, and silicones. Wacker Chemie has a strong focus on innovation and sustainability, with R centers located in Germany, the United States, and China. It is listed on the Frankfurt and Munich stock exchanges and its shares are also traded on the OTC market under the symbol WKCMF.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Wacker Chemie AG | 0.00% |
| iShares Core DAX® | 0.396% |
| iShares Nasdaq 100 | 0.881% |
| iShares Nikkei 225® | 1.405% |
| iShares S&P 500 | 0.259% |
According to DerAlmanach100000 what are the pros and cons of Wacker Chemie AG for the foreseeable future?
Pros
Revenue growth > 30% per year expected
Undervalued
Small challenges to pay loans and raise capital
Very capable Management
Very good company culture
Strong uniques
Growths much faster than the competition
Could be very worthwhile Investment >20% year
Top Rating
Leading role in innovation
Very differentiated customer and product portfolio
Market Leader or Top 3
Very Future proof/growth oriented business model
Well known brand
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Wacker Chemie AG diskutieren
Buy Wacker Chemie AG
Stopped prediction by DerAlmanach100000 for Wacker Chemie AG
Wacker Chemie AG
Start price
Target price
Perf. (%)
€66.50
07.05.25
07.05.25
-
07.05.27
07.05.27
5.86%
23.07.25
23.07.25
Revenue growth > 30% per year expected
Undervalued
Small challenges to pay loans and raise capital
Very capable Management
